CERO THERAPEUTICS HOLDINGS, INC. Shareholders' Equity
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Shareholders' Equity of -$30.51 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-14
- 2026-06-30: Stockholders' Equity Attributable to Parent -$30.51M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$9.26M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$5.45M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$4.54M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | -$30.51M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$9.26M 10-Q · filed 2026-08-14 | |
| 2025-12-31 | -$5.45M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$4.54M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | -$1.63M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | -$329.39K 10-Q · filed 2026-08-14 | |
| 2024-12-31 | -$1.89M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | -$3.70M 10-Q/A · filed 2024-11-20 | |
| 2024-06-30 | -$2.48M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$3.98M 10-Q · filed 2024-05-17 | |
| 2024-02-14 | -$2.35M 10-K · filed 2026-04-15 | |
| 2023-12-31 | -$42.06M 10-K · filed 2025-04-15 | -$14.20M 10-K · filed 2024-04-02 |
| 2023-09-30 | -$13.77M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$13.29M 10-Q · filed 2023-11-09 | |
| 2023-03-31 | -$11.58M 10-Q · filed 2023-11-09 | |
| 2022-12-31 | -$11.00M 10-K · filed 2024-04-02 | -$10.76M 10-K · filed 2023-03-24 |
| 2022-09-30 | -$9.06M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | -$8.16M 10-Q · filed 2023-11-09 | |
| 2022-03-31 | -$8.05M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | -$7.67M 10-K · filed 2024-04-02 | |
| 2021-09-30 | $24.00K 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $24.00K 10-Q · filed 2022-11-10 | |
| 2021-06-07 | $0.00 10-K · filed 2023-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |